Allosteric regulation of HIV-1 reverse transcriptase by atp for nucleotide selection

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Yokoyama, Masaru ^a   Mori, Hiromi ^a   Sato, Hironori ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA; NUCLEOSIDE ANALOG; NUCLEOTIDE; PROTEIN P66; RNA DIRECTED DNA POLYMERASE; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ALLOSTERISM; ARTICLE; BINDING SITE; CATALYSIS; COMPUTER ANALYSIS; DNA SYNTHESIS; EXCISION; GENE INSERTION; GENE MUTATION; GEOMETRY; MOLECULE; MUTAGENESIS; NONHUMAN; PHYSIOLOGY; POLYMERIZATION; PREDICTION; PROBABILITY; STRUCTURE ANALYSIS; BIOCATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; GENETICS; KINETICS; METABOLISM; MUTATION; SITE DIRECTED MUTAGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADENOSINE TRIPHOSPHATE; ALLOSTERIC REGULATION; BIOCATALYSIS; HIV REVERSE TRANSCRIPTASE; KINETICS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 77749242511     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008867     Document Type: Article

References (34)

1. Huang H, Chopra R, Verdine GL, Harrison SC (1998) Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282: 1669-1675.
2. Preston BD, Poiesz BJ, Loeb LA (1988) Fidelity of HIV-1 reverse transcriptase. Science 242: 1168-1171.
3. Roberts JD, Bebenek K, Kunkel TA (1988) The accuracy of reverse transcriptase from HIV-1. Science 242: 1171-1173.
4. Goodman MF (1997) Hydrogen bonding revisited: geometric selection as a principal determinant of DNA replication fidelity. Proc Natl Acad Sci U S A 94: 10493-10495.
5. Kunkel TA, Bebenek K (2000) DNA replication fidelity. Annu Rev Biochem 69: 497-529.
6. Kunkel TA (2004) DNA replication fidelity. J Biol Chem 279: 16895-16898.
7. Traut TW (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140: 1-22.
8. Meyer PR, Matsuura SE, So AG, Scott WA (1998) Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proc Natl Acad Sci U S A 95: 13471-13476.
9. Arion D, Kaushik N, McCormick S, Borkow G, Parniak MA (1998) Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 37: 15908-15917.
10. Meyer PR, Matsuura SE, Mian AM, So AG, Scott WA (1999) A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol Cell 4: 35-43.
11. Das K, Sarafianos SG, Clark AD Jr, Boyer PL, Hughes SH, et al. (2007) Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097. J Mol Biol 365: 77-89.
12. Sarafianos SG, Marchand B, Das K, Himmel DM, Parniak MA, et al. (2009) Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol 385: 693-713.
13. Sato H, Tomita Y, Ebisawa K, Hachiya A, Shibamura K, et al. (2001) Augmentation of human immunodeficiency virus type 1 subtype E (CRF01-AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase. J Virol 75: 5604-5613.
14. Sarafianos SG, Clark AD Jr, Das K, Tuske S, Birktoft JJ, et al. (2002) Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA. Embo J 21: 6614-6624.
15. Ray AS, Murakami E, Basavapathruni A, Vaccaro JA, Ulrich D, et al. (2003) Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis. Biochemistry 42: 8831-8841.
16. Marchand B, White KL, Ly JK, Margot NA, Wang R, et al. (2007) Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir. Antimicrob Agents Chemother 51: 2911-2919.
17. Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, et al. (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A 83: 8333-8337.
18. Vrang L, Bazin H, Remaud G, Chattopadhyaya J, Oberg B (1987) Inhibition of the reverse transcriptase from HIV by 3′-azido-3′-deoxythymidine triphosphate and its threo analogue. Antiviral Res 7: 139-149.
19. Baker D, Sali A (2001) Protein structure prediction and structural genomics. Science 294: 93-96.
20. Kati WM, Johnson KA, Jerva LF, Anderson KS (1992) Mechanism and fidelity of HIV reverse transcriptase. J Biol Chem 267: 25988-25997.
21. Rittinger K, Divita G, Goody RS (1995) Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors. Proc Natl Acad Sci U S A 92: 8046-8049.
22. Goto J, Kataoka R, Muta H, Hirayama N (2008) ASEDock-docking based on alpha spheres and excluded volumes. J Chem Inf Model 48: 583-590.
23. Chen R, Yokoyama M, Sato H, Reilly C, Mansky LM (2005) Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies. J Virol 79: 12045-12057.
24. Li Y, Kong Y, Korolev S, Waksman G (1998) Crystal structures of the Klenow fragment of Thermus aquaticus DNA polymerase I complexed with deoxyribonucleoside triphosphates. Protein Sci 7: 1116-1123.
25. Johnson SJ, Taylor JS, Beese LS (2003) Processive DNA synthesis observed in a polymerase crystal suggests a mechanism for the prevention of frameshift mutations. Proc Natl Acad Sci U S A 100: 3895-3900.
26. Yin YW, Steitz TA (2004) The structural mechanism of translocation and helicase activity in T7 RNA polymerase. Cell 116: 393-404.
27. Temiakov D, Patlan V, Anikin M, McAllister WT, Yokoyama S, et al. (2004) Structural basis for substrate selection by t7 RNA polymerase. Cell 116: 381-391.
28. Thompson AA, Albertini RA, Peersen OB (2007) Stabilization of poliovirus polymerase by NTP binding and fingers-thumb interactions. J Mol Biol 366: 1459-1474.
29. Petruska J, Goodman MF, Boosalis MS, Sowers LC, Cheong C, et al. (1988) Comparison between DNA melting thermodynamics and DNA polymerase fidelity. Proc Natl Acad Sci U S A 85: 6252-6256.
30. Ling H, Boudsocq F, Woodgate R, Yang W (2001) Crystal structure of a Y-family DNA polymerase in action: a mechanism for error-prone and lesionbypass replication. Cell 107: 91-102.
31. Ling H, Boudsocq F, Plosky BS, Woodgate R, Yang W (2003) Replication of a cis-syn thymine dimer at atomic resolution. Nature 424: 1083-1087.
32. Starnes MC, Cheng YC (1989) Human immunodeficiency virus reverse transcriptase-associated RNase H activity. J Biol Chem 264: 7073-7077.
33. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, et al. (1988) In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 62: 139-147.
34. Shirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, et al. (2008) Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat Struct Mol Biol 15: 1184-1191.